Tuberculous meningitis (TBM), the most severe extra-pulmonary manifestation of tuberculosis, is caused by Mycobacterium tuberculosis. The M. tuberculosis complex (MTBC) includes seven lineages, all described to harbor a unique geographical dissemination pattern and clinical presentation.
IntroduCtIon
The infectious disease tuberculosis (TB) is a major global health problem caused by infection with the pathogen Mycobacterium tuberculosis. Tuberculous meningitis (TBM), one of the most severe extra pulmonary manifestations of TB, can develop once M. tuberculosis disseminates from its primary pulmonary focus. TBM is generally accepted to be a consequence of pre-existing granulomatous lesions in the central nervous system (CNS), so-called Rich foci. Once these foci rupture into the subarachnoid space the subsequent inflammatory response induces meningitis (Donald et al., 2005; Rich and McCordock, 1933) .
The Mycobacterium tuberculosis complex (MTBC) encompasses seven large-sequence polymorphisms (LSP) based lineages that are adapted to humans, all characterized by a unique global distribution. Lineages 2, also known as East-Asian lineage, and 4, the Euro-American lineage, show the most extensive distribution worldwide. In contrast, lineage 5 and 6 (Mycobacterium africanum, West-African lineages) are restricted to WestAfrica and lineage 7 (Ethiopia lineage) is almost exclusively found in Ethiopia. Lineages 1 (Indo-Oceanic) and 3 (East-African-Indian) display a more intermediate distribution (Brites and Gagneux, 2017; Stucki et al., 2016) . The geographical distribution of lineages might suggest that lineages are adapted to particular human population groups (Stucki et al., 2016) . In addition, individual lineages are linked to distinct patterns of pathology and disease severity. Several studies suggest that infections with Beijing strain isolates (belonging to lineage 2) are more frequently associated with extra-pulmonary TB and TBM Maree et al., 2007; Pan et al., 2015; Xing et al., 2012) . Other associations found with the Beijing strain are a more acute presentation of disease and younger age, indicating that this lineage is most pathogenic (Faksri et al., 2011; Thwaites et al., 2008; Yorsangsukkamol et al., 2009 ). In contrast, lineage 4 was associated with a higher prevalence of pulmonary TB compared to TBM, suggesting a protective association with this lineage Faksri et al., 2011) . In South Africa, a study among 285 children showed no difference in susceptibility to TBM between the prevalence of two dominant sub-strains belonging to lineage 2 and 4 (Nicol et al., 2005) , indicating that both strains might contribute to CNS involvement equally in this population.
Infection with M. tuberculosis is not restricted to infection with a single lineage. This so called mixed infection, or genetic heterogeneity, is present in 10-20% of sputum cultures from individual TB patients and can have an enormous influence on treatment outcome and can select for drug resistance (Cohen et al., 2016; Van Rie et al., 2005) . The presence of genetic heterogeneity has not been described in cerebrospinal fluid (CSF) of patients with TBM so far. Since detection is restricted to our limited ability to culture bacteria from the CSF and is dependent on the sensitivity of the genotyping method used (Cohen et al., 2012; Plazzotta et al., 2015; Wilkinson et al., 2017) , the actual number of patients with genetic heterogeneity in the CNS is most likely underestimated.
This present study aims to genotype M. tuberculosis lineage 1, 2, 3 and 4, most commonly found in the Western Cape of South Africa, directly from granulomas and inflammatory foci in brain tissue. To achieve this, we use an historical cohort of brain specimen from children and adults with severe stages of TBM. Within this paucibacillary tissue we demonstrate that lineage 4 is the most commonly detected lineage in our cohort. Furthermore, we could identify genetic heterogeneity within brain specimens and show for the first time that infection of the CNS is not restricted to a single M. tuberculosis lineage.
MAterIAls And Method study cohort
Material for this study was selected from a historical cohort study (Zaharie et al, unpublished data) , consisting of brain specimen from children (<14 years, n=40) and adults (>14 years, n=43) with proven or probable TBM registered at the Department of Anatomical Pathology between 1975 and 2012. Patients with medical records, radiographic imaging and neuropathology brain specimen available were included (n=83), specimen were obtained post-mortem (n=76) or with diagnostic biopsy during life (n=7). In total, the database contains 452 blocks (one to 22 blocks available per patient). For this current study, one or two blocks from each patient were selected based on positive ZN staining. In-house crude DNA from cultured samples were included as technical controls for all tested bacterial lineages.
sample preparation
The formalin-fixed paraffin embedded (FFPE) brain tissues were cut using a microtome (block size 8-54 cm 2) . To minimize contamination risk, new microtome blades were used and cleaning with xylene, 100% ethanol and 10% bleach was done between blocks. Three to five slices of 10 µm (depending on block size) were stored for processing in 1.5 ml Eppendorf® Safe-Lock micro centrifuge tubes.
dnA extraction
DNA extraction was performed using the NucleoSpin® DNA FFPE XS kit (Macherey Nagel, Düren, Germany), with protocol adjusted to the amount of tissue. This kit is based on a proteinase K lysis buffer DNA extraction, using a silica membrane column to minimize the loss of DNA. Obtained eluate was directly suitable for PCR.
Polymerase Chain reaction Applications and sanger sequencing
Eluates obtained after DNA extraction were used for PCR to amplify the region of interest. The QIAgen HotstarTaq® Plus Master Mix Kit (Qiagen, Hilden, Germany) was used with following cycling conditions: initial denaturation: 10 minutes, 95°C; 40 cycles of 90 seconds denaturation at 94°C; 30 seconds at a suitable annealing temperature, dependent of T m of primers and 1 minute of extension at 72°C, with a final elongation at 72°C for 15 minutes.
To differentiate lineage 1, RD239 deletion was determined. To differentiate lineage 2, RD105 deletion was determined. RD181 deletion, RD150 deletion and RD142 deletion were determined to differentiate between lineage 2 sub-lineages. Lineage 3 was determined by RD750 deletion.
Primers for the RD105 deletion were designed and adapted based on previous described work (Hanekom et al., 2013) . The remaining primers were designed with http:// genolist.pasteur.fr/TubercuList/) using the flanking regions of the RDs (Tsolaki et al., 2004) . Because of expected fragmentation of DNA, previously published primers could not be used. Details of all primer sequences and their regions are shown in supplemental table S1. Gel electrophoresis with 2% agarose combined with GR Green DNA dye was used for detection of the bands. Gels ran until a clear difference between band sizes of positive and negative controls were visible (51-150 base pair difference). To differentiate lineage 4, deletion of pks15/1 was determined (Gagneux et al., 2006) . PCR products, visible bands on agarose gel, were sent for Sanger Sequencing to Inqaba Biotech (CT, South Africa).
h&e, rs and Zn-staining
Slides were stained according to conventional protocol with Hemotoxin Eosin (H&E), Reticulin Silver (RS) and Ziehl Neelsen (ZN) staining and analyzed by a skilled neuropathologist. Three categories were defined based on bacterial load identified on ZN staining with light microscopy (4.2 high power field). Low bacterial load was defined as one or less bacteria per mm 2 , medium bacterial load was defined as 2-20 bacteria per mm 2 , and high bacterial load was defined as more than 20 bacteria per mm 2 .
statistical analysis
The database with patient information was managed with IBMM SPSS Statistics, version 23.0.0.0 (SPSS Inc., Chicago, IL, USA). Statistical analysis and creation of graphs was performed with the same program. Differences between children and adults were tested presenting p-values for Chi-square test (Fisher's Exact test for cell size less than five), Mann-Whitney U (median), and independent-samples t-test (mean). The correlation between sample age and PCR success rate, and between ZN positivity and PCR success rate was tested with Spearman's correlation. Significance was measured at p=0.05. These analyses were done with IBM statistics version 25 (IMB Corporation, South Africa).
ethics
The study was approved by the Human Research Ethics Committee of Stellenbosch University, Cape Town, Western Cape, South Africa (ethics approval number S12/11/298). Informed consent for this study was waivered. The post-mortem collection of neuropathology material was originally collected during patient admission at Tygerberg Hospital as part of standard care and available because the patient or their family provided permission for initial autopsy at the time.
results baseline characteristics
Bacterial characterization could be performed on FFPE neuro-pathology material of 46 TBM patients (55%) with conclusive DNA (Zaharie et al, unpublished data). On pathological examination, the diagnosis TBM was probable when clear parenchymal inflammation and granulomas were found, and proven when additional ZN positive bacteria were found or when the CSF culture was positive for bacteria. Median age of the total population was 5.6 years (0.5-65.5). Most patients were men (60.9%) and had a mixed ancestry background (76.7%). Data on immunization was not available for most children (1/9, 11.1%, received BCG), and 11/21 (52.4%) had a registered TB contact in the household. The majority of patients presented with TBM stage 3 (61%) on admission and had proven TBM (62.2%). 17 children were on the local standard 4-drug regimen of Isoniazid, Rifampicin, Pyrazinamid and Ethionamide (73.9%) and duration between start of therapy until autopsy was 7 days (range 0-153) ( Table 1) . Proven TBM with a positive ZN staining was more frequently seen in children than adults. Due to the historical time frame of this cohort, HIV co-infection and MDR or XDR M. tuberculosis was not recorded.
Paucibacillary tissue limits PCr based genotyping
In order to genotype M. tuberculosis, DNA was extracted from the available samples and bacteria were genotyped using a PCR-based method. However, two difficulties were encountered. Firstly, the FFPE samples used in this cohort were stored for decades and most samples were stored in (buffered) formalin for an unknown time period before embedding in paraffin was performed. Therefore, the extracted DNA was most likely highly fragmented, cross-linked and degraded (Miething et al., 2006) . Median sample age in years was 27.7 (IQR: 23.2-32.6, range 6.2-39.7), age of the block was not associated with success of PCR-based genotyping (p>0.05). Secondly, although the diagnosis of TBM was probable in all patients based on histopathological examination, ZN staining was negative for 12/46 patients (26.1%) and positive for the remaining 34 patients. Additionally, a low ZN positivity was found in the 
lineage 4 is most prevalent in Cns granulomas between 1975 and 2002
Genotyping of lineage 4 was successful in 46 cases. Lineage 4 was identified in 26 samples (56,5%), non-lineage 4 was found in 10 cases (21,7%) and a genetic heterogenic infection of lineage 4 and non-lineage 4 was found in another 10 cases (21,7%) ( Figure  1) . Age of the sample was not associated with detected lineage (p>0.05) (Figure 2 TBM study cohort n=83 Figure 1 . study flow Study flow of samples analyzed in the current study. Samples were tested with a PCR based method to identify the presence or absence of RD239 (lineage 1), RD105 (lineage 2) and RD750 (lineage 3). A selection of cases was further analyzed to examine subsets of lineage 2 by studying the presence or absence of RD181, RD150 or RD142. Lineage 4 was genotyped by sequencing of obtained PCR products and we could successfully determine the presence or absence of pks 15/1 in 46 cases (bold). *inconclusive results due to poor DNA quality; **missing results due to limited amount of DNA or PCR not performed when three previous PCRs were inconclusive.
number of inconclusive results.Lineage distribution could therefore not be determined in the non-lineage 4 group or group with genetic heterogenic infection (Figure 1 ).
Genetic heterogenic infection in children
Genetic heterogeneity was identified in 7 patients > 14 year and 3 children < 14 years (total 10 patients=20.4%). All children were between 2 and 3 years of age and their samples were included in 1984, 1986 and 1992 (Table 2) . Case 1 and 2 presented with TBM stage IIa, in which mild neurological symptoms were present. Case 3 presented with TBM stage III and showed improvement of staging during treatment. Both Case 1 and 3 experienced a rapid disease progression with miliary TB. Both patients deceased within 3 weeks of presentation, despite intensive treatment with at least four different tuberculostatics. Case 2 deceased without involvement of other organs and after longer treatment duration of 52 days.
On neuropathological examination, all three patients showed chronic inflammation in the leptomeninges, poorly formed granulomas and fibrosis. Acute inflammation was present in patient Case 2. All three cases were ZN negative (Figure 3 ). In this study, we could successfully identify lineage 4 as predominant strain in CNS granulomas. At Tygerberg Hospital, the hospital where this study is performed, 14.9% of all culture confirmed TB cases under the age of 14 years consists of TBM (Schaaf et al., 2007) . However, little information was available about lineage specificity until recently. Based on previous studies performed in the same region, lineage 4 was expected to be most prevalent in pulmonary TB (Cowley et al., 2008) and lineage 2 was expected to be most prevalent in children with TBM (Maree et al., 2007) . However, additional studies show an equal distribution of lineage 2 and 4 for both pulmonary and extra-pulmonary TB (Brites and Gagneux, 2017; Nicol et al., 2005) . Lineage 4, also known as the Euro-American lineage, is geographically the most wide spread lineage and shows a substantial variation among different ethnic groups and in different clinical settings (Stucki et al., 2016) . This diversity might be explained by the fact that it consists of ten different sub-lineages which are suggested to have adopted their own successful strategies to their specific population. The overrepresentation of lineage 4 in TBM samples might be unexpected, but most of the previous studies were performed in Vietnam, China and Thailand. The wide spread geographical variation of strains suggests the possibility of a different M. tuberculosis genotype distribution among the South African population as described here Faksri et al., 2011; Maree et al., 2007; Pan et al., 2015; Thwaites et al., 2008; Wang et al., 2016; Xing et al., 2012; Yorsangsukkamol et al., 2009 ). The predominance of lineage 4 can be explained by the hypothesis that lineage distribution is subject to time in addition to geography. A study performed in Cape Town with archived post-mortem samples reported an increase in infection with Beijing strain over the past decades. This strain was never found before 1966, but prevalence significantly increased after 1995. Simultaneously, the proportion of Euro-American strains declined (Cowley et al., 2008) . Although a correlation between time and prevalence was not found in the current cohort, the effect of altering prevalence of specific strains cannot be completely excluded.
The second finding in this study is the presence of more than one M. tuberculosis lineage within the CNS of a single patient. Genetic heterogeneity, in lung tissue, in which multiple lineages can be found in a single individual at the same time, is in fact not new. Numerous reports, including a South African cohort in the same region as the current study, report 10-20% of sputum cultures containing more than one M. tuberculosis lineage (Cohen et al., 2016 (Cohen et al., , 2012 Hanekom et al., 2013; Plazzotta et al., 2015) . However, this is likely an underestimation of the actual amount of genetic heterogenic infections due to the difficulty to isolate these strains and differences in genotyping method (Cohen et al., 2012; Plazzotta et al., 2015; Zheng et al., 2015) . In addition to the presence of multiple strains in sputum samples, heterogenic populations of strains were also found in spleen, blood and lymph nodes (Cohen et al., 2012) , indicating that genetic heterogeneity is not restricted to the lung. The current study is the first to identify genetic heterogeneity in the CNS in both adults and children, in ten patients out of 46 patient, similar to 21,7% occurrence described in literature (Cohen et al., 2016 (Cohen et al., , 2012 Hanekom et al., 2013; Plazzotta et al., 2015) . Laboratory contamination during sample processing cannot be ruled out completely, however it can be assumed to only contribute to a small proportion (maximum 4%) of genetic heterogeneity (Warren et al., 2004) .
Genetic heterogeneity is thought to be a consequence of reinfection after an incomplete recovery of a previous M. tuberculosis infection and it has been hypothesized that this second strain may reactivate the primary infection (Cohen et al., 2012; Hanekom et al., 2013) . In young children, the amount of genetic heterogenic infection is thought to be reduced due to the rapid progression of disease and the small time frame in which reinfection can occur (Plazzotta et al., 2015; Wilkinson et al., 2017) . Therefore, the genetic heterogeneity identified in the CNS of three young children was a major surprise. Hypothetically, a high rate of reinfection can exist in areas with a high M. tuberculosis burden. Subsequently, once the first strain entered the CNS a reinfection can easily trigger progression of disease in the vulnerable brain of a child with a relative immature immune system.
Although genetic heterogeneity was identified, the combination of the historical sample collection with partly degraded DNA and the chosen genotyping methods did not allow for a further characterization of sub-lineages. Spoligotyping of Manu2 strain, belonging to lineage 1, has been associated with finding mixed infection when using PCR-based genotyping methods in pulmonary TB (Zheng et al., 2015) . Manu2 strains has also been isolated from the CSF of children with TBM in China, suggesting the possibility of mixed infection in these patients (Xing et al., 2012) . Additionally, an overrepresentation of Beijing strains in genetic heterogenic pulmonary infections has been described as well (Hanekom et al., 2013) . However, due to the low prevalence of Beijing strain isolates before 1995 in this population, a predominance of this strain is uncertain in the current study (Cowley et al., 2008) .
A limiting factor to our study was the paucibacillary nature of the samples, restricting our ability to detect enough DNA for strain determination, but also CSF of patients with active TBM have an extremely low bacterial load (Wilkinson et al., 2017) . Therefore, it is questionable if it were possible to identify a large number of bacteria at a single location in an individual patients' brain specimen. Another limitation was the archived FFPE samples which were stored in buffered or unbuffered formalin for an unknown period of time under unknown circumstances with most likely damaging effects on the samples (Miething et al., 2006) . Given the paucibacillarity of the specimen and previous genotyping studies describing inconclusive results on FFPE material with spoligotyping (Tsolaki et al., 2004) , PCR based genotyping seemed the best option to distinguish the different lineages. However, this method resulted in a large proportion of inconclusive results as well. Results were more certain when PCR products were sequenced, but unfortunately we were not able to acquire complete information about genetic variation of M. tuberculosis lineages present in the CNS.
Taken together, this unique cohort reveals valuable insight in the overrepresentation of lineage 4 and the presence of genetic heterogenic infection in the CNS of young children in TBM samples in the Western Cape of South Africa over the past decades. This might explain the rapid progression of disease and insufficient response to standard therapy seen in this population. Not only the advanced stage of TBM can explain outcome of this patient group, also the genetic heterogeneity may contribute to treatment unresponsiveness leading to unfavorable outcome. Flanking region L GGGACCAAGC (Tsolaki et al, 2004) Flanking region R AGGTCGTACG (Tsolaki et al, 2004) supplemental Flanking region L ACGTTCGTAT (Tsolaki et al, 2004) Flanking region R CTAGCGCGTC (Tsolaki et al, 2004) Primer 
